Antimalarial compounds: From bench to bedside

Journal of Experimental Biology

Volumn 206, Issue 21, 2003, Pages 3753-3759

  Olliaro, Piero L ^a   Taylor, Walter R J ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Artemisinin; Drug development; Malaria

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; SESQUITERPENE;

AGE; ANIMAL; CLINICAL TRIAL; DRUG COMBINATION; DRUG DESIGN; DRUG RESISTANCE; MALARIA; PLASMODIUM; REVIEW;

AGE FACTORS; ANIMALS; ANTIMALARIALS; ARTEMISININS; CLINICAL TRIALS; DRUG COMBINATIONS; DRUG DESIGN; DRUG RESISTANCE; MALARIA; PLASMODIUM; SESQUITERPENES;

ANIMALIA;

EID: 0242490370     PISSN: 00220949     EISSN: None     Source Type: Journal    
DOI: 10.1242/jeb.00653     Document Type: Review

References (35)

1. Adjuik, M., Agnamey, P., Babiker, A., Borrmann, S., Brasseur, P., Cisse, M., Cobelens, F., Diallo, S., Faucher, J. F., Garner, P. et al. (2002). Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 359, 1365-1372.
2. Baird, J. K., Basri, H., Subianto, B., Fryauff, D. J., McElroy, P. D., Leksana, B., Richie, T. L., Masbar, S., Wignall, F. S. and Huffman, S. L. (1995). Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J. Infect. Dis. 171, 1678-1682.
3. Denis, M. B., Davis, T. M., Hewitt, S., Incardona, S., Nimol, K., Fandeur, T., Poravuth, Y., Lim, C. and Socheat, D. (2002). Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin. Infect. Dis. 35, 1469-1476.
4. Greenwood, B. M., Bradley, A. K., Greenwood, A. M., Byass, P., Jammeh, K., Marsh, K., Tulloch, S., Oldfield, F. S. J. and Hayers, R. (1987) Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans. R. Soc. Trop. Med. Hyg. 81, 478-486.
5. Kumar, N. and Zheng, H. (1990). Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol. Res. 76, 214-218.
6. Lang, T. and Greenwood, B. (2003). The development of Lapdap, an affordable new treatment for malaria. Lancet Infect. Dis. 3, 162-168.
7. Legros, D., Johnson, K., Houpikian, P., Makanga, M., Kabakyenga, J. K., Talisuna, A. O. and Taylor, W. R. (2002). Clinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 96, 199-201.
8. Lell, B., Ruangweerayut, R., Wiesner, J., Missinou, M. A., Schindler, A., Baranek, T., Hintz, M., Hutchinson, D., Jomaa, H. and Kremsner, P. G. (2003). Fosmidomycin, a novel chemotherapeutic agent for malaria. Antimicrob. Agents Chemother. 47, 735-738.
9. Looareesuwan, S., Kyle, D. E., Viravan, C., Vanijanonta, S., Wilairatana, P. and Wernsdorfer, W. H. (1996). Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Trans. R. Soc. Trop. Med. Hyg. 54, 205-209.
10. Marsh, V. M., Mutemi, W. M., Muturi, J., Haaland, A., Watkins, W. M., Otieno, G. and Marsh, K. (1999). Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Trop. Med. Int. Health 4, 383-389.
11. McGready, R., Cho, T., Keo, N. K., Thwai, K. L., Villegas, L., Looareesuwan, S., White, N. J. and Nosten, F. (2001). Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. Clin. Infect. Dis. 33, 2009-2016.
12. Missinou, M. A., Borrmann, S., Schindler, A., Issifou, S., Adegnika, A. A., Matsiegui, P. B., Binder, R., Lell, B., Wiesner, J., Baranek, T. et al. (2002). Fosmidomycin for malaria. Lancet 360, 1941-1942.
13. Murphy, S. C. and Breman, J. G. (2001). Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am. J. Trop. Med. Hyg. 64, 57-67.
14. Mutabingwa, T., Nzila, A., Mberu, E., Nduati, E., Winstanley, P., Hills, E. and Watkins, W. (2001). Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 358, 1218-1223.
15. Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K. L., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S. and White, N. J. (2000). Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356, 297-302.
16. Ogutu, B. R., Smoak, B. L., Nduati, R. W., Mbori-Ngacha, D. A., Mwathe, F. and Shanks, G. D. (2000). The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children. Trans. R. Soc. Trop. Med. Hyg. 94, 83-84.
17. Omari, A. A., Preston, C. and Garner, P. (2003). Artemether-lumefantrine for treating uncomplicated falciparum malaria. Cochrane Database Syst. Rev. 2, CD003125.
18. Plowe, C. (2003). Monitoring antimalarial drug resistance: making the most of the tools at hand. J. Exp. Biol. 206, 3745-3752.
19. Price, R. N., Nosten, F., Luxemburger, C., ter Kuile, F. O., Paiphun, L., Chongsuphajaisiddhi, T. and White, N. J. (1996). Effects of artemisinin derivatives on malaria transmissibility. Lancet 347, 1654-1658.
20. Ringwald, P., Bickii, J. and Basco, L. (1996). Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet 347, 24-28.
21. Rosenthal, P. J. (2003). Antimalarial drug discovery: old and new approaches. J. Exp. Biol. 206, 3735-3744.
22. Sulo, J., Chimpeni, P., Hatcher, J., Kublin, J. G., Plowe, C. V., Molyneux, M. E., Marsh, K., Taylor, T. E., Watkins, W. M. and Winstanley, P. A. (2002). Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial. Lancet 360, 1136-1143.
23. Targett, G., Drakeley, C., Jawara, M., von Seidlein, L., Coleman, R., Deen, J., Pinder, M., Doherty, T., Sutherland, C., Walraven, G. et al. (2001) Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J. Infect. Dis. 183, 1254-1259.
24. Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R. and Ford, N. (2002). Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet 359, 2188-2194.
25. van Vugt, M., Looareesuwan, S., Wilairatana, P., McGready, R., Villegas, L., Gathmann, I., Mull, R., Brockman, A., White, N. J. and Nosten, F. (2000). Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94, 545-548.
26. von Seidlein, L., Milligan, P., Pinder, M., Bojang, K., Anyalebechi, C., Gosling, R., Coleman, R., Ude, J. I., Sadiq, A., Duraisingh, M. et al. (2000). Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 355, 352-357.
27. Vugt, M. V., Wilairatana, P., Gemperli, B., Gathmann, I., Phaipun, L., Brockman, A., Luxemburger, C., White, N. J., Nosten, F. and Looareesuwan, S. (1999). Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 60, 936-942.
28. Watkins, W. M. and Mosobo, M. (1993). Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans. R. Soc. Trop. Med. Hyg. 87, 75-78.
29. White, N. J. (1992). Antimalarial drug resistance: the pace quickens. J. Antimicrob. Chemother. 30, 571-585.
30. White, N. J. (1997). Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41, 1413-1422.
31. White, N. J. (1999). Delaying antimalarial drug resistance with combination chemotherapy. Parasitologia 41, 301-308.
32. White, N. J. and Olliaro, P. (1998). Artemisinin and derivatives in the treatment of uncomplicated malaria. Med. Trop. 58(Suppl), 54-56.
33. White, N. J., Nosten, F., Looareesuwan, S., Watkins, W. M., Marsh, K., Snow, R. W., Kokwaro, G., Ouma, J., Hien, T. T., Molyneux, M. E. et al. (1999). Averting a malaria disaster. Lancet 353, 1965-1967.
34. Wongsrichanalai, C., Pickard, A. L., Wernsdorfer, W. H. and Meshnick, S. R. (2002). Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2, 209-218.
35. World Health Organization (2001). Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation. WHO/CDS/RBM/2001.35. Geneva, Switzerland: World Health Organization.